Maricann Expands European Management Team and Provides Clinical Trial Update

TORONTO, June 20, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI) (FRANKFURT:75M) (OTCQB:MRRCF) (“Maricann” or the “Company) is pleased to provide the following update with regards to the Company’s European operations.
Given the rapid expansi…

Do NOT follow this link or you will be banned from the site!